Net income Fiscal Year (2023): $800,000,000,000
Committed to transparency, we present a snapshot of our recent financial year, showcasing our commitment to financial excellence.
We appreciate your trust. For inquiries, please contact Investor Relations at investors@assocengrs.com
We surpassed expectations this year, exceeding our revenue goals. This success stems from our commitment to innovation, market expansion, and strong customer relationships.
Join us in celebrating a year of financial success, where each dollar earned reflects your trust.
- Total Revenue: $800,000,000,000, 2022-2023
- Total Assets: $5,000,000,000,000,000,
- Net Income: $500,000,000,000
- Gross profit: $320,000,000,000
| Total revenue | $800,000,000,000. (2023) |
| Gross profit | $320,000,000,000 |
| Operational expenses | $300,000,000,000. |
| EBITDA | $200,000,000,000 |
| Income before tax | $120,000,000,000 |
2024 new projects
Current project portfolio
Biochemical research
Location: London
Oil & Gas
Location: UAE
Grial Power Plant
Project location: German
Gross profit 2022-2023
Indicates the profitability of our core operations after accounting for the cost of goods sold.
Operational expenses
Operating expenses demonstrates our ability to manage and control day-to-day business costs.
EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization)